1 / 65

CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease. General Data:. Name: Baby Boy G Neonate born of a 22 year old primigravida. History of the Present Illness. Initial prenatal check-up 6 th month of pregnancy at local health center CBC, urinalysis normal

sue
Download Presentation

CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

  2. General Data: • Name: Baby Boy G • Neonate • born of a 22 year old primigravida

  3. History of the Present Illness • Initial prenatal check-up • 6th month of pregnancy at local health center • CBC, urinalysis normal • UTZ (9/6/10): right ventricle appears collapsed • Single live intrauterine pregnancy, cephalic, good cardiac and somatic activity, 24-25 weeks AOG, rule out hypoplastic right ventricle. • Suggests congenital anomal scan scan with detailed cardiac evaulation preferably using fetal echocardiogram • Referred to USTH

  4. September 8, 2010 • UTZ: 2nd and 3rd trimester • Single live intrauterine pregnancy of about 24-25 weeks in breech presentation with good cardiac and somatic activity • Suggest fetal 2D echo c/o Dr. Cuaso

  5. September 8, 2010 • Assessment: Pregnancy 24-25 weeks AOG based on 2nd trimester ultrasound, t/c hypoplastic right ventricle • Advised: • Multivitamins + FESO4 1 cap OD • Milk formula 1 glass OD • Request for CBC with blood typing, urinalysis, 50g OGCT • Request for congenital scan • Attend mother’s class every Saturday 10-11 am

  6. September 13, 2010

  7. September 13, 2010

  8. September 16, 2010 • OB GYN OPD • Speculum exam: cervix violaceous, smooth with moderate frothy yellowish creamy discharge • Assessment: Trichomoniasis • Advised: Metronidazole 500 mg/tab 1 tab BID • Fetal 2D Echo once with funds • 50g OGCT, repeat urinalysis clean catch

  9. September 24, 2010 • Follow-up • Unremarkable • Still for fetal 2D Echo, 50g OGCT

  10. October 5, 2010 • (+) terminal dysuria • Urinalysis • Acidic • (++) bacteria • 2-5/hpf pus cells • Normal OGCT results • Advised: • Amoxicillin 500 mg/tab 1 tab q8 for 7 days • Once with 2D Echo results, refer to pediatric surgery • (+) hyperemic conjunctiva OD- referred to Ophtha

  11. October 15, 2010 • USTH (October 11, 2010) • Fetal 2D- Echocardiogram: hypoplastic Left Ventricle, hypoplastic Mitral Valve, and a patent foramen ovale • FHT 142 • Assessment: Pregnancy 29-30 weeks, hypoplastic left heart • Advised: • Refer to pediatrics-cardiology and pediatric surgery

  12. November 22, 2010 • (+) persistence of dysuria • Assessment: Pregnancy 35-36 weeks AOG, cephalic, Hypoplastic left ventricle, t/c UTI • Advised • Urinalysis, Hepatitis B Ag, Blood typing

  13. November 25, 2010 • Assessment: UTI • Advised: • Amoxicillin 500mg/cap 1 cap q8 for 7 days • Increase oral fluid intake

  14. November 25, 2010 • Pediatric Surgery Consult • Assessment: Pregnancy 36 weeks AOG, (?) hypoplastic left ventricle • Plans: will evaluate any time after delivery

  15. November 26, 2010 • Blood type: AB+

  16. December 10, 2010 • UTZ: 2nd and 3rd trimester • There seems to be a mass in the interventricular septum • Single live intrauterine pregnancy of about 35-36 weeks in cephalic presentation • BPS 8/8; SEFW 2823 grams • Cardiomegaly • Suggest referral to Dr. Cuaso

  17. December 10, 2010 • High Risk OB GYN clinic • Assessment: Hypoplastic left ventricle, hypoplastic mitral valve, UTI, r/o IUGR • Advised: Terraferon, Clusivol OB, Cefuroxime 500 mg/tab BID for 7 days • Repeat urinalysis after 7 days • BPS

  18. December 17, 2010 • UTZ: 38 weeks 6 days AOG • (-) dysuria • (+) fetal movements, irregular hypogastric pains, SEFW p10-50 • IE: 1 cm dilated, 60% effaced, (+) BOW, cephalic, Stn-3 • Assessment: Pregnancy 38-39 weeks, cephalic, not in labor, ? Mass at the interventricular septum, UTI s/p treatment

  19. December 12, 2010 • UTZ: 2nd and 3rd trimester • Findings: • There seems to be a mass at the interventricular septum • Single live intrauterine pregnancy of about 35-36 weeks in cephalic presentation • BPS 8/8; SEFW 2823 grams • Cardiomegaly • Suggest referral to Dr. Cuaso

  20. December 20, 2010 • For follow up • Supposedly for repeat Fetal 2D Echo • 3 cm dilated, 70% effaced intact BOW, there was progression of labor alongside with spontaneous rupture of BOW. • Clear, non-foul smelling amniotic fluid

  21. Maternal History • (-)exposure to radiation • (-) symptoms of viral exanthems • (-) use of illicit drugs and abortifacients • Non-smoker • Non drinker of alcoholic beverages • (-) hypertension, allergy, thyroid disease, diabetes, asthma, liver disease, or blood dyscrasia • Hep B screening non-reactive • OGCT normal

  22. Family History

  23. Family History • No diabetes, hypertension, cardiac diseases, cancer, tuberculosis, allergies • Denies hereditary illnesses

  24. Physical Examination • General Data • live, term, singleton, male, delivered via normal spontaneous delivery • BW 2.75 kg, BL 48 cm • AS 6 and 7 at 5 minutes, MT 38-39 weeks • AGA

  25. Physical Examination on Admission • HR 134 bpm, RR 58 cpm, T 37.2˚C • Blue, pale, (+) circumoral cyanosis • (-) Rash, (-) birth marks, (+) palmar and plantar cyanosis • (+) Molding, (+) caput succedaneum (-) cephalhematoma • (+) ROR OU, (-) eye discharge, normal set ears, (-) preauricular pits, patent nares, (-) Epstein’s pearls

  26. Physical Examination on Admission • (-) Palpable neck masses, intact clavicle, no crepitations • (-) Chest deformities, symmetrical chest expansion, (-) retractions, clear and equal breath sounds, good respiratory effort • Adynamicprecordium, regular heart rate and rhythm, grade 1 holosystolic murmur at left parasternal area • Globular abdomen, (+) umbilical stump with 2 arteries and 1 vein, (-) organomegaly, (-) palpable masses

  27. Grossly male, bilaterally descended testes, good rugae, patent anus • Femoral pulses full and equal, good flexion of extremities, (-) Barlow, (-) Ortolani • Straight spine, (-) sacral dimpling, (-) tuft of hair • (+) Moro, grasp, rooting, plantar, and sucking reflexes

  28. APPROACH TO DIAGNOSIS OF A PATIENT PRESENTING WITH CYANOSIS AT BIRTH

  29. Indicators that heart disease may exist • Cyanosis • Cardiomegaly (Radiologic or Pericardial bulge) • Pathologic heart murmur • Tachypnea or overt respiratory distress (dyspnea) • Sweating especially during feeding • Increased or decreased pulses • Failure to thrive

  30. Classification of Congenital Heart Diseases A) Acyanotic B) Cyanotic

  31. Major Considerations • Is there a shunt (LR or RL) • Is there obstruction to inflow or outflow • Abnormal heart valves • Abnormal connections of great vessels • Combination

  32. Subgroups of Acyanotic Diseases • Shunt anomalies • Valvular defects • Obstructive lesions • Inflow anomalies • Primary myocardial diseases

  33. Shunt Anomalies • L  R shunt • Increased pulmonary blood flow • Increased pulmonary vascular arterial markings on chest Xray • ASD, VSD, PDA

  34. Obstructive Lesion • Discrepancy in amplitude of the peripheral pulses • Coarctation of the Aorta

  35. Inflow Anomalies • Increased pulmonary venous markings on chest Xray • No murmur • Cor Triatriatum, Pulmonary vein stenosis

  36. Valvular Defects • Stenosis or regurgitant • Characteristic murmur • AS, AR, PS, PR, MS, MR, TS, TR

  37. Primary Myocardial Diseases • No murmur • Disparity between cardiac size and pulmonary vascular markings • Glycogen storage disease • Cardiomyopathy

  38. Hemodynamic Consequences A) Volume (Diastolic) overload B) Pressure (Systolic) overload

  39. ASD Hemodynamic Consequence Diastolic overload of RV

  40. VSD • Hemodynamic Consequence • MODERATE SIZE • Volume overload of LV • LARGE SIZE • Volume overload of LV • Pressure overload of RV

  41. Cyanotic Heart Disease • Cyanotic heart disease exist when one defect or association of defects allow the mixture of saturated and de-saturated blood to reach the systemic circulation

  42. Do you suspect that patient is Cyanotic? • When in doubt • Clubbing • CBC • Hyperoxia test

  43. Hyperoxia Test • Hyperoxia test is considered positive for intracardiac shunting if PO2 < 150 mmHg (torr) after 10 minutes of 100% fiO2

  44. PVA / IVS • Hemodynamic Consequence • Pressure overload of RV

  45. PVA / VSD • Hemodynamic Consequence • Pressure overload of RV

  46. PDA Dependent Pulmonary Circulation • Pulmonary valve atresia (PVA) with intact interventricular septum • Other lesions with accompanying PVA

  47. Approach to diagnosis

  48. Chest x-ray

  49. Causes of Cyanosis

  50. Pulmonary Vascular MarkingsDecreased: Cyanotic

More Related